By the end of this course the participant should:
- Have a grasp of current concepts in lung, pleural and mediastinal pathology
- Understand the importance of correlation between clinical, radiologic and pathologic data in diagnosis and management of interstitial lung disease and pulmonary vasculitis
- Know the significance of lung biopsy and multidisciplinary correlation for the diagnosis of non-neoplastic lung disease in acute lung injury and in cancer patients
- Comprehend the most recent histologic concepts in lung cancer diagnosis and classification including problematic issues related to molecular pathology and radiologic correlations
- Realize the important issues in molecular targeted therapy for lung cancer
- Have a practical understanding of differential diagnosis for mediastinal and pleural lesions
- Understand the usefulness of cytology in pulmonary, pleural and mediastinal diagnoses
This course will be invaluable for pathologists, pulmonologists, thoracic surgeons, and radiologists, including physicians in training.
Memorial Sloan Kettering Cancer Center designates this educational activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This program will include SAM credits.